LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

Search

Stryker Corp

Suletud

SektorTervishoid

363.69 2.57

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

353.71

Max

363.87

Põhinäitajad

By Trading Economics

Sissetulek

-25M

859M

Müük

35M

6.1B

P/E

Sektori keskmine

47.188

77.256

Aktsiakasum

3.19

Dividenditootlus

0.94

Kasumimarginaal

14.182

Töötajad

53,000

EBITDA

-108M

1.4B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+20.94% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.94%

2.33%

Turustatistika

By TradingEconomics

Turukapital

-9.7B

137B

Eelmine avamishind

361.12

Eelmine sulgemishind

363.69

Uudiste sentiment

By Acuity

23%

77%

57 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Stryker Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

30. okt 2025, 20:36 UTC

Tulu

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31. juuli 2025, 20:42 UTC

Tulu

Stryker Lifts Guidance on Improving Tariff Outlook

1. mai 2025, 20:56 UTC

Tulu

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

5. nov 2025, 19:38 UTC

Tulu

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5. nov 2025, 17:00 UTC

Tulu

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30. okt 2025, 20:21 UTC

Tulu

Stryker Lifts FY Sales View After 3Q Revenue Rises

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Adj EPS $3.19 >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q EPS $2.22 >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Sales $6.1B >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Net $859M >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Adj EPS $3.19 >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Net $859M >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q Sales $6.06B >SYK

30. okt 2025, 20:05 UTC

Tulu

Stryker 3Q EPS $2.22 >SYK

31. juuli 2025, 20:09 UTC

Tulu

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31. juuli 2025, 20:09 UTC

Tulu

Stryker Sales >SYK

31. juuli 2025, 20:09 UTC

Tulu

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Sales $6B >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Net $884M >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q EPS $2.29 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Adj EPS $3.13 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q Sales $6B >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q EPS $2.29 >SYK

31. juuli 2025, 20:05 UTC

Tulu

Stryker 2Q EPS $2.29 >SYK

1. mai 2025, 20:41 UTC

Tulu

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1. mai 2025, 20:11 UTC

Tulu

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1. mai 2025, 20:10 UTC

Tulu

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1. mai 2025, 20:05 UTC

Tulu

Stryker 1Q Adj EPS $2.84 >SYK

Võrdlus sarnastega

Hinnamuutus

Stryker Corp Prognoos

Hinnasiht

By TipRanks

20.94% tõus

12 kuu keskmine prognoos

Keskmine 430.6 USD  20.94%

Kõrge 455 USD

Madal 392 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Stryker Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

15 ratings

12

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

373.92 / 383.99Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

57 / 374 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat